Today, a new cervical cancer screening program in Lesotho is making headway against this deadly epidemic. Lesotho’s National Cervical Cancer Prevention Program at the Senkatana Centre of Excellence, pioneered by EGPAF in partnership with the U.S. Agency for International Development (USAID) and the Lesotho Ministry of Health, is using simple, innovative methods to identify cervical cancer in its earliest stages and cure the disease before it can progress. Keep reading
Dan Hartmann is living with HIV, while his wife, Susan, is HIV-free – they are a discordant couple. When they decided to have a baby, they did so with careful planning and research. The choices they made to build their family highlight the current global research in treating and preventing this disease. Keep reading
There are many children who contracted HIV as infants, through mother-to-child transmission, growing into adolescents. As sexuality develops in this phase of life, so too does the risk of contracting HIV. This is a uniquely underreported and high-risk group. At one EGPAF-supported site in Kenya, staff are doing all they can to support their local teens. Keep reading
In the March 2015 issue of The Lancet HIV, EGPAF’s Senior Director of Technical Leadership, Innovations, and Sustainability Francesca Celletti, M.D. is the lead author on a new commentary outlining the need for HIV treatment and elimination targets for child living with HIV. Keep reading
We sat down with EGPAF board member Dr. Mike McCune and his daughter Emma to learn how together they are making the effort to end AIDS in children a family affair. Keep reading
Multilateral funding models such as Gavi, the Global Fund, and UNITAID, leverage the strengths of the disparate sectors of the global health community, public and private, to achieve maximum financial and programmatic effect. Keep reading
Today (Feb. 24) the Medicines Patent Pool (MPP) announced a new licensing agreement with pharmaceutical company Merck & Co. that will allow generic manufacturers to produce low-cost pediatric versions of Merck's HIV medication, raltegravir. Read a blog from MPP's Executive Director Greg Perry on the importance of these agreements. Keep reading
The Conference on Retroviruses and Opportunistic Infections (CROI), an annual conference which gathers leading researchers in the field of HIV and AIDS will be held February 23-25. The Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) will be in attendance to present its latest research from Rwanda and to collect information to inform our country programs. Keep reading
In our latest installment of HIV 101, we help our readers understand a few terms that might seems like synonyms to the average person, but each has a very different meaning to public health experts, especially when it comes to ending serious public health threats like HIV/AIDS. Keep reading
